This shows that EFNA1-EPHA2 in immuno_CA may contribute to malignant progression, including as the proliferation and metastasis of tumor cells, and that reducing its expression or blocking endogenous activation of EFNA1-EPHA2 regulatory axis may play a role in tumor inhibition. The gene discussed is EPHA2; the disease is neoplasm.